PodcastsSciencePharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive Podcast
Pharmaceutical Executive
Latest episode

275 episodes

  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist

    2026/1/27 | 1 mins.
    In today’s pharmaceutical executive daily, Roche reports positive Phase II results for a dual GLP-1/GIP receptor agonist, procurement leaders reassess compliance risks tied to unmanaged tail spend, and Boehringer Ingelheim enters a $1 billion collaboration with Simcere to advance bispecific antibody research.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: Mirum Pharmaceuticals Acquires Bluejay Therapeutics

    2026/1/26 | 1 mins.
    In todays pharmaceutical executive daily, Mirum Pharmaceuticals strengthens its rare disease portfolio through a $268 million acquisition, industry experts examine why data visualization remains a weak point in biotech decision-making, and pediatricians weigh in on evolving vaccine guidance amid ongoing debate.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: Tariff Uncertainty Accelerates Manufacturing Shifts

    2026/1/23 | 1 mins.
    In today’s Pharmaceutical Executive Daily, tariff uncertainty triggers a short-term surge in pharmaceutical manufacturing activity, workforce burnout threatens the stability of the blood supply, and industry leaders assess whether artificial intelligence in pharma is reaching a critical inflection point.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: United States' Set to Exit WHO

    2026/1/22 | 1 mins.
    In today’s Pharmaceutical Executive Daily, the World Health Organization finalizes the United States’ withdrawal from the global health body, Bristol Myers Squibb enters an $850 million collaboration with Janux Therapeutics to advance tumor-activated cancer therapies, and industry leaders examine how real-world data is increasingly shaping patient access decisions.
  • Pharmaceutical Executive

    Pharmaceutical Executive Daily: New Study Finds No Evidence Linking Tylenol Use to Autism Risk

    2026/1/21 | 1 mins.
    In today’s Pharmaceutical Executive Daily, a new study reignites debate over a potential link between Tylenol use and autism risk, TopGum signs a $12 million letter of intent to acquire US manufacturing operations, and industry leaders weigh whether to build or buy AI capabilities amid accelerating digital transformation.

More Science podcasts

About Pharmaceutical Executive

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 
Podcast website

Listen to Pharmaceutical Executive, StarTalk Radio and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Social
v8.3.1 | © 2007-2026 radio.de GmbH
Generated: 1/28/2026 - 8:45:36 PM